-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
November 02, 2018 - narrow eligibility criteria or when study
population characteristics (e.g., age, race, sex, presence or lack
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-future_research.pdf
February 01, 2013 - determine
changes in patient status and to modify/redirect intervention based upon clinical findings
or lack
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-surgical-report-cards.pdf
November 01, 2023 - Quality of MBSAQIP data: bad luck, or lack
of QA plan?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_executive.pdf
May 01, 2013 - study of diagnostic accuracy blinded caregivers to the
results of risk-assessment scores; and this lack
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary29/obstructive-sleep-apnea-in-adults-screening
November 15, 2022 - diabetes and 1 who used opioids for chronic pain
Both studies had a moderate risk of bias due to lack
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obstructive-sleep-apnea-in-adults-screening-january-2017
January 24, 2017 - referral populations
Small total sample size (type II), missing data (types II and IV), and some lack
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - Lack of
efficacy of acetaminophen in treating
symptomatic knee osteoarthritis: a
randomized, double-blind
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
December 01, 2010 - This lack of generalizability is
demonstrated by the wide variability across our four topics.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp5.pdf
October 01, 2011 - Lack
of effect of a low-fat, high-fiber diet on the
recurrence of colorectal adenomas.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/b5LjDb3-UoPV8LEWavJWB8
February 01, 2010 - Risks of these
medications should be weighed against
the fact that both drugs lack evidence
of persistence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
September 06, 2016 - The lack of a direct test for LTBI re-
quires test accuracy studies to be performed in specific, nonprimary
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
November 01, 2021 - Because of reporting bias
around serious harms other than perforation and bleeding, as well
as the lack
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/tpc/estimating-costs-primary-care-transformation.pdf
July 31, 2015 - • Respondents may have limited expertise in cost data collection and a lack of familiarity
with practice
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
July 01, 2014 - recommended against screening asymptomatic persons for
HBV infection (D recommendation) on the basis of a lack
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
April 01, 2015 - variables that were not measured
at both baseline and followup (e.g., birth weight, length of stay), or lack
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
June 01, 2013 - strict control
3
arm, relatively small sample size, enrollment of primarily
low-risk patients, and lack
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-chsp-tin-linkage-file-tech-doc.pdf
January 01, 2018 - Comparative Health System Performance Initiative: Compendium of U.S. Health Systems, 2016, Group Practice Linkage File, Technical DocumentationComparative Health System Performance Initiative: Compendium of U.S. Health Systems, 2016, Group Practice Linkage File, Technical Documentation
Comparative Health System Pe…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
June 09, 2020 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Evidence Summary
Unhealthy Drug Use: Screening
June 09, 2020
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
May 23, 2019 - Screening Adults for Type 2 Diabetes: A Review of the Evidence for
the U.S. Preventive Services Task Force
Russell Harris, MD, MPH; Katrina Donahue, MD, MPH; Saif S. Rathore, MPH; Paul Frame, MD; Steven H. Woolf, MD, MPH;
and Kathleen N. Lohr, PhD
Background: Type 2 diabetes mellitus is associated with a
heavy burden …
-
www.ahrq.gov/news/newsroom/ahrq-stats.html
July 01, 2025 - AHRQ Stats
New data nuggets from AHRQ News Now posted weekly to highlight AHRQ statistical reports on health care trends. Adverse Drug Events Involving Hypoglycemic Agents In 2021, 7.5 percent of Hispanic patients, 6.6 percent of Black patients, 6.2 percent of patients with an “other” or unknown race, and 4.0…